{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:20:19Z","timestamp":1789676419343,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Stiftung f\u00fcr angewandte Krebsforschung \/ Foundation for Applied Cancer Research, Zurich"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Systemic response to local anticancer treatment is a phenomenon called \u2018abscopal effect\u2019. The immune system is thought to play a pivotal role in its occurrence. To date, several cases have been reported, particularly in patients receiving combined local treatment and immune checkpoint inhibitors. In such cases, it is impossible to discriminate between the effects of local and systemic treatment. Only a few cases of abscopal effect have been described with radiotherapy alone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we report on the case of an 81-year-old woman with recurrent metastatic squamous cell carcinoma of the lung with mediastinal tumor bulk, lymph node and bone metastases. The patient refused to undergo systemic treatment, and palliative stereotactic radiotherapy of the mediastinal tumor was performed. At restaging with FDG-PET\/CT, the patient presented with a decrease in size and FDG-avidity both of the irradiated site and of the lymph node and bone metastases (which did not receive radiotherapy). At 25\u00a0months after radiotherapy, the patient is still in remission at all sites.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is a rare case of an abscopal effect after radiotherapy as monotherapy. It is one of the few hitherto reported for lung cancer. Several ongoing studies with a combination of radiotherapy and immunotherapy are seeking to exploit a potential synergy to induce abscopal effects.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-021-01920-4","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T14:45:42Z","timestamp":1633358742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["True abscopal effect in a patient with metastatic non-small cell lung cancer"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0866-1367","authenticated-orcid":false,"given":"Oliver","family":"Vilinovszki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Huellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Curioni-Fontecedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie G. C.","family":"Kroeze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,2]]},"reference":[{"key":"1920_CR1","doi-asserted-by":"crossref","unstructured":"Seiwert TY, Kiess AP. Time to debunk an urban myth? The \u201cabscopal effect\u201d with radiation and anti-pd-1. J Clin Oncol. 2021;39(1):1\u20133.","DOI":"10.1200\/JCO.20.02046"},{"issue":"2","key":"1920_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s13566-019-00391-1","volume":"8","author":"MA D'Andrea","year":"2019","unstructured":"D\u2019Andrea MA, Reddy GK. The systemic immunostimulatory effects of radiation therapy producing overall tumor control through the abscopal effect. J Radiat Oncol. 2019;8(2):143\u201356.","journal-title":"J Radiat Oncol"},{"issue":"1","key":"1920_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000510287","volume":"99","author":"MA D'Andrea","year":"2021","unstructured":"D\u2019Andrea MA, Reddy GK. Systemic effects of radiation therapy-induced abscopal responses in patients with advanced lung cancer. Oncology. 2021;99(1):1\u201314.","journal-title":"Oncology"},{"issue":"1","key":"1920_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.currproblcancer.2015.10.001","volume":"40","author":"Y Abuodeh","year":"2016","unstructured":"Abuodeh Y, Venkat P, Kim S. Systematic review of case reports on the abscopal effect. Curr Probl Cancer. 2016;40(1):25\u201337.","journal-title":"Curr Probl Cancer"},{"key":"1920_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fonc.2014.00325","volume":"4","author":"RE Vatner","year":"2014","unstructured":"Vatner RE, Cooper BT, Vanpouille-Box C, Demaria S, Formenti SC. Combinations of immunotherapy and radiation in cancer therapy. Front Oncol. 2014;4:325.","journal-title":"Front Oncol"},{"issue":"3","key":"1920_CR6","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","volume":"58","author":"S Demaria","year":"2004","unstructured":"Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys. 2004;58(3):862\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"1920_CR7","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2217\/imt-2019-0105","volume":"11","author":"E Garelli","year":"2019","unstructured":"Garelli E, Rittmeyer A, Putora PM, Glatzer M, Dressel R, Andreas S. Abscopal effect in lung cancer: three case reports and a concise review. Immunotherapy. 2019;11(17):1445\u201361.","journal-title":"Immunotherapy"},{"key":"1920_CR8","doi-asserted-by":"crossref","unstructured":"Agrawal V, Benjamin KT, Ko EC. Radiotherapy and immunotherapy combinations for lung cancer. Curr Oncol Rep. 2021;23(1):4.","DOI":"10.1007\/s11912-020-00993-w"},{"issue":"4","key":"1920_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2478\/raon-2018-0037","volume":"52","author":"M Vrankar","year":"2018","unstructured":"Vrankar M, Unk M. Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy. Radiol Oncol. 2018;52(4):365\u20139.","journal-title":"Radiol Oncol"},{"issue":"661","key":"1920_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1259\/0007-1285-56-661-63","volume":"56","author":"GJG Rees","year":"1983","unstructured":"Rees GJG, Ross CMD. Abscopal regression following radiotherapy for adenocarcinoma. Br J Radiol. 1983;56(661):63\u20136.","journal-title":"Br J Radiol"},{"issue":"12","key":"1920_CR11","first-page":"14","volume":"10","author":"AJ Hamilton","year":"2018","unstructured":"Hamilton AJ, Seid J, Verdecchia K, Chuba P. Abscopal effect after radiosurgery for solitary brain metastasis from non-small cell lung cancer. Cureus. 2018;10(12):14.","journal-title":"Cureus"},{"key":"1920_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12885-019-5566-8","volume":"19","author":"A Kuroda","year":"2019","unstructured":"Kuroda A, Tabuchi T, Iwami E, Sasahara K, Matsuzaki T, Nakajima T, et al. Abscopal effect of radiation on multiple lung metastases of lung adenocarcinoma: a case report. BMC Cancer. 2019;19:5.","journal-title":"BMC Cancer"},{"issue":"2","key":"1920_CR13","first-page":"365","volume":"9","author":"K Katayama","year":"2017","unstructured":"Katayama K, Tamiya A, Koba T, Fukuda S, Atagi S. An abscopal response to radiation therapy in a patient with metastatic non-small cell lung cancer: a case report. J Cancer Sci Ther. 2017;9(2):365\u20137.","journal-title":"J Cancer Sci Ther"},{"issue":"21","key":"1920_CR14","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","volume":"379","author":"L Paz-Ares","year":"2018","unstructured":"Paz-Ares L, Luft A, Vicente D, Tafreshi A, Gumus M, Mazieres J, et al. Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Engl J Med. 2018;379(21):2040\u201351.","journal-title":"N Engl J Med"},{"issue":"1","key":"1920_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3322\/caac.21358","volume":"67","author":"FG Herrera","year":"2017","unstructured":"Herrera FG, Bourhis J, Coukos G. Radiotherapy combination opportunities leveraging immunity for the next oncology practice. Ca-a Cancer J Clin. 2017;67(1):65\u201385.","journal-title":"Ca-a Cancer J Clin"},{"issue":"6","key":"1920_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ctrv.2015.03.011","volume":"41","author":"K Reynders","year":"2015","unstructured":"Reynders K, Illidge T, Siva S, Chang JY, De Ruysscher D. The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant. Cancer Treat Rev. 2015;41(6):503\u201310.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"1920_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.clon.2010.10.002","volume":"23","author":"T Liu","year":"2011","unstructured":"Liu T, Xu J-Y, Xu W, Bai Y-R, Yan W-L, Yang H-L. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best? - a meta-analysis. Clin Oncol. 2011;23(5):350\u20138.","journal-title":"Clin Oncol"},{"issue":"2","key":"1920_CR18","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1002\/ijc.27779","volume":"132","author":"Y Wu","year":"2013","unstructured":"Wu Y, Li P, Zhang H, Shi Y, Wu H, Zhang J, et al. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography\/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Int J Cancer. 2013;132(2):E37\u201347.","journal-title":"Int J Cancer"},{"issue":"7","key":"1920_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/intimm\/dxw026","volume":"28","author":"YC Lu","year":"2016","unstructured":"Lu YC, Robbins PF. Targeting neoantigens for cancer immunotherapy. Int Immunol. 2016;28(7):365\u201370.","journal-title":"Int Immunol"},{"key":"1920_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharmthera.2018.12.002","volume":"196","author":"ME Rodriguez-Ruiz","year":"2019","unstructured":"Rodriguez-Ruiz ME, Rodriguez I, Leaman O, Lopez-Campos F, Montero A, Conde AJ, et al. Immune mechanisms mediating abscopal effects in radioimmunotherapy. Pharmacol Ther. 2019;196:195\u2013203.","journal-title":"Pharmacol Ther"},{"issue":"23","key":"1920_CR21","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1158\/1078-0432.CCR-17-3620","volume":"24","author":"EC Ko","year":"2018","unstructured":"Ko EC, Raben D, Formenti SC. The integration of radiotherapy with immunotherapy for the treatment of non-small cell lung cancer. Clin Cancer Res. 2018;24(23):5792\u2013806.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1920_CR22","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamaoncol.2019.1478","volume":"5","author":"W Theelen","year":"2019","unstructured":"Theelen W, Peulen HMU, Lalezari F, van der Noort V, de Vries JF, Aerts J, et al. Effect of pembrolizumab after stereotactic body radiotherapy vs pembrolizumab alone on tumor response in patients with advanced non-small cell lung cancer: results of the PEMBRO-RT phase 2 randomized clinical trial. JAMA Oncol. 2019;5(9):1276\u201382.","journal-title":"JAMA Oncol"},{"key":"1920_CR23","doi-asserted-by":"crossref","unstructured":"McBride S, Sherman E, Tsai CJ, Baxi S, Aghalar J, Eng J, et al. Randomized phase II trial of nivolumab with stereotactic body radiotherapy versus nivolumab alone in metastatic head and neck squamous cell carcinoma. J Clin Oncol. 2021;39(1):30\u20137.","DOI":"10.1200\/JCO.20.00290"},{"issue":"7","key":"1920_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.clon.2019.04.006","volume":"31","author":"D Xing","year":"2019","unstructured":"Xing D, Siva S, Hanna GG. The abscopal effect of stereotactic radiotherapy and immunotherapy: Fool\u2019s Gold or El Dorado? Clin Oncol. 2019;31(7):432\u201343.","journal-title":"Clin Oncol"},{"key":"1920_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fmed.2019.00244","volume":"6","author":"M Spaas","year":"2019","unstructured":"Spaas M, Lievens Y. Is the Combination of immunotherapy and radiotherapy in non-small cell lung cancer a feasible and effective approach? Front Med. 2019;6:16.","journal-title":"Front Med"},{"issue":"8","key":"1920_CR26","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.3390\/cancers12082178","volume":"12","author":"R Chicas-Sett","year":"2020","unstructured":"Chicas-Sett R, Zafra-Martin J, Morales-Orue I, Castilla-Martinez J, Berenguer-Frances MA, Gonzalez-Rodriguez E, et al. Immunoradiotherapy as an effective therapeutic strategy in lung cancer: from palliative care to curative intent. Cancers. 2020;12(8):2178.","journal-title":"Cancers"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01920-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-021-01920-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01920-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T15:09:29Z","timestamp":1633360169000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-021-01920-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1920"],"URL":"https:\/\/doi.org\/10.1186\/s13014-021-01920-4","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,2]]},"assertion":[{"value":"22 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This report has been performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient consented to publication of the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.H. is a recipient of grants from GE Healthcare, grants for translational and clinical cardiac and oncological research from the Alfred and Annemarie von Sick legacy, and grants from the Clinical Research Priority Program (CRPP) Artificial Intelligence in oncological Imaging Network by the University of Zurich. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}